JPRN-UMIN000014934已完成4 期
A study for effectiveness and safety of tocilizumab therapy in rheumatoid arthritis patients with renal insufficiency. - Tocilizumab for rheumatoid arthritis patients with renal insufficiency
HO Kumamoto Saishunsou National Hospital0 个研究点目标入组 400 人开始时间: 2014年8月25日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Tocilizumab in severe COVID-19COVID-19.COVID-19U07.1IRCT20150303021315N17Aryogen Pharmed85
已完成
4 期
Study for Predictors of Effectiveness in Tocilizumab Therapy (PETITE)rheumatoid ArthritisJPRN-UMIN000002246Osaka City University Medical School, Center for Senile Degerative Disorders (CSDD)50
招募中
2 期
Evaluation the Efficacy and Safety of Tocilizumab in COVID-19COVID-19 pneumonia.Confirmed diagnosis of COVID-19RA01.0IRCT20151227025726N13Shahid Beheshti University of Medical Sciences40
已完成
不适用
Clinical trial of long term efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHDThe patients with systemic sclerosis or sclerodermatous chronic GVHD.JPRN-UMIN000022624Kanazawa University Hospital5
已完成
不适用
Efficacy and Safety of treatment with tocilizumab in refractory patients with Takayasu ArteritisTakayasu arteritisJPRN-UMIN000007845Department of Cardiovascular Medicine Graduate School of Medicine Osaka University15